Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a new revision of the page. This update represents a minor system-level change rather than any modification to the study information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a minor release/version change without affecting the study details shown.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision bumped from v3.4.3 to v3.5.0. This appears to be an internal site update with no visible changes to the study details or related content.SummaryDifference0.0%

- Check65 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. This appears to be a version bump with no visible changes to page content.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded Revision: v3.4.2. Removed the Notice about government funding lapse and the prior Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.